-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Daclatasvir, an efficient inhibitor of the hepatitis C virus replication complex protein NS5A: review of virologic data, treatment ationale and clinical trials.
Stanislas Pol
Review: Clinical Trail Outcomes: Clinical Investigation
-
Daclatasvir, an efficient inhibitor of the hepatitis C virus replication complex protein NS5A: review of virologic data, treatment ationale and clinical trials.
Stanislas Pol
Review: Clinical Trail Outcomes: Clinical Investigation
-
Daclatasvir, an efficient inhibitor of the hepatitis C virus replication complex protein NS5A: review of virologic data, treatment ationale and clinical trials.
Stanislas Pol
Review: Clinical Trail Outcomes: Clinical Investigation
-
Daclatasvir, an efficient inhibitor of the hepatitis C virus replication complex protein NS5A: review of virologic data, treatment ationale and clinical trials.
Stanislas Pol
Review: Clinical Trail Outcomes: Clinical Investigation
-
Daclatasvir, an efficient inhibitor of the hepatitis C virus replication complex protein NS5A: review of virologic data, treatment ationale and clinical trials.
Stanislas Pol
Review: Clinical Trail Outcomes: Clinical Investigation
-
Daclatasvir, an efficient inhibitor of the hepatitis C virus replication complex protein NS5A: review of virologic data, treatment ationale and clinical trials.
Stanislas Pol
Review: Clinical Trail Outcomes: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Randomization in clinical trials: can we eliminate bias?
Oleksandr Sverdlov,William F Rosenberger
Clinical Trail Prospective: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions?
Robert Hemmings, David Wright
Interview: Clinical Investigation